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Benign myoclonic epilepsy in infancy (BMEI) is a rare syndrome of idiopathic generalized epilepsies with onset below 3 years of age. It
has been reported that BMEI is associated with a good prognosis, however, recently some studies suggest less favourable neuropsychological
outcome. We report a long-term follow-up of seven patients with BMEI. Seizure outcome and neuropsychological, cognitive, and
behavioural evolution were discussed for each of them. At the end of follow-up, 86% of children showed neuropsychological and intellectual
disorders: two children had mental retardation, three patients achieved a borderline IQ and one normal but low IQ. All but one displayed
neuropsychological disabilities including fine motor skill deficits, attention deficits, and language impairment and learning disorders. Our
clinical data and the previous reports suggest that the early onset of the seizures may be one of the main factors of the illness giving rise to a
less favourable outcome. Additional interacting factors such as delayed start of treatment, and efficacy of the drugs may play an important
role, too. We believe that BMEI does not exert, different from some epileptic encephalopathies, a quick destroying effect but may interfere
with the growth of developing functions, which results in long-term neuropsychological disabilities.
q 2004 Elsevier B.V. All rights reserved.
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Benign myoclonic epilepsy in infancy (BMEI), deli-
neated by Dravet and Bureau in 1981 [1], is a rare syndrome
of idiopathic generalized epilepsies (IGE) with onset below
3 years of age. There is a prevalence of males with a ratio of
approximately 2–1. About 30% of affected children has a
family history of epilepsy or febrile convulsions (FC).
The seizures occur in healthy infants, and are character-
ized by brief generalized myoclonic jerks involving the axis
of the body and limbs. They usually last 1–3 s and are
isolated, although sometimes they occur in cluster. BMEI is
never associated with other seizure types, but rare FC may
precede or follow the onset of myoclonic attacks.
Ictal EEG shows brief generalized 3 Hz spike-wave
(SW) or polyspike-wave (PSW) discharges increasing
during drowsiness. Seizures are well controlled by sodium0387-7604/$ - see front matter q 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.braindev.2004.04.011
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E-mail address: manganos@katamail.com (S. Mangano).valproate (VPA) but relapses have been reported in few
patients later in adolescence requiring reintroduction of the
drug [2]. Although BMEI prognosis has been considered
favourable, some studies suggest a less favourable neuro-
psychological outcome [2–5].
The disagreement on long-term outcome of BMEI
induced us to investigate the seizure-associated factors
that may be involved in cognitive and behavioural
development. We report a long-term follow-up of seven
patients with BMEI. Seizure outcome and neuropsycholo-
gical, cognitive, and behavioural evolution were discussed.2. Patients and methods
Seven children (three males and four females) with a
mean age of 8 years 1 month (range: 5 years 8 months–10
years 2 months) were enrolled among 1110 epileptic
patients who were referred to the Child Neuropsychiatry
Clinic of University of Palermo between January 1992Brain & Development 27 (2005) 218–223www.elsevier.com/locate/braindev
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were required to have a diagnosis of BMEI according to the
criteria reported by the Classification of Epilepsies and
Epileptic Syndromes [6], normal developmental milestones
at first hospital admission, and lack of markers suggesting a
pre-existing encephalopathy. The average duration of the
follow-up was 6 years 9 months (range: 4 years 9 months–9
years 2 months). We investigated the following data: (a)
family history, personal past history and postnatal troubles;
(b) psychomotor development; (c) neurological examin-
ation; (d) brain CT scan; (e) age at onset of myoclonic
seizures (MS); (f) clinical and EEG features of seizures; (g)
antiepileptic treatment; (h) interval between seizure onset
and starting antiepileptic drugs (AED); (i) seizure and EEG
evolution; (j) long-term neuropsychological, cognitive, and
behavioural outcome.
Neuropsychological profiles were constructed on the
basis of different tests, depending on the characteristics of
each patient. The Brunet-Le´zine scale was used to assess the
psychomotor development. The Wechsler Preschool and
Primary Scale of Intelligence (WPPSI) and the Wechsler
Intelligence Scale for Children-Revised (WISC-R) were
administered to determine verbal and performance IQ. We
used the Bender Visual Motor Gestalt Test (BVMGT as
scored by Santucci for Italian sample) to measure visual-
motor integration and the oral language test (TVLO as
scored by Ferrari et al. for Italian sample) to assess language
abilities. Recalling sentences (RS) and spontaneous speech
(SS) subtests were used to assess expressive syntax. The
token test (TT) and visual naming (VN) subtests were used
to measure receptive syntax and vocabulary.
Although no behavioural questionnaire was adminis-
tered, we paid close attention to possible emotional or
behavioural problems (such as anxiety, shyness, hyperac-
tivity, aggressiveness, irritability, oppositional conduct,Table 1
Benign myoclonic epilepsy in infancy: clinical characteristics
No.
pat.
Sex Family
history
FC before
MS start
Age at
MS onset
Age/
psychomotor
development
at first hospital
admission
1 F K K 7 months 9 months/
normal
2 F FC C 7 months 11 months/
normal
3 M EPI – 11 months 15 months/
normal
4 M – C 12 months 12 months/
normal
5 F – – 14 months 15 months/
normal
6 M FC C 22 months 22 months/
normal
7 F EPI – 35 months 36 months/
normal
FC, febrile convulsions; EPI, epilepsy; MS, myoclonic seizures; AED, antiepilepand attention problems) during clinical follow-up. Infor-
mations were obtained by parent and teacher interviews and
by clinical observations.3. Results
Clinical data of our patients are reported in Table 1. Four
patients (57%) had a family history of epilepsy and FC. No
patient had notable past history and postnatal troubles.
Three infants experienced FC before onset of MS. At the
first hospital admission, findings of neurological examin-
ation and psychomotor development were normal in all
patients. Brain computed tomography scan in two patients
(cases 1 and 2) did not show any abnormality. Mean age at
onset of MS was 15 months (range: 7 months–35 months).
Myoclonic jerks occurred at 7 months of age in two children
(29%), between 11 and 14 months in three patients (43%), at
22 and 35 months in two patients (29%), respectively. The
seizures were characterized by myoclonic jerks involving
mainly the upper limbs in all patients, and in some cases
they provoked nodding with upward gaze deviation,
bending of the body axis and flexing or reduction of tone
in the lower limbs. MS occurred many times a day and were
never associated with other seizures. Ictal EEG recordings
showed generalized SW and/or PSW discharges synchro-
nous with myoclonus (Fig. 1), and interictal EEG showed no
abnormalities (Fig. 2). Two children (29%) had myoclonus
triggered by tactile or acoustic stimuli. VPA was effective in
all patients but one who needed clobazam add-on. The
average interval between seizure onset and VPA adminis-
tration was 2 months 15 days (range: 18 days–5 months).
The patients became seizure-free within a mean period of
7 months 15 days (range: 10 days–28 months) with
disappearance of generalized SW and/or PSW dischargesAED Interval
between
MS onset
and start
of AED
Interval
between
start of AED
and seizure
control
Age at
seizure
control
Duration
of follow-up
VPAC
CLB
2 months 28 months 37 months 7 years
7 months
VPA 4 months 10 days 11 months 4 years
9 months
VPA 5 months 6 months 22 months 7 years
6 months
VPA 18 days 3 months 16 months 9 years
2 months
VPA 1 month 6 months 21 months 7 years
2 months
VPA 1 month 4 months 27 months 5 years
2 months
VPA 2 months 1 month 38 months 6 years
2 months
tic drug; VPA, valproic acid; CLB, clobazam.
Fig. 1. Patient 2: the ictal EEG shows w3 Hz generalized high-amplitude spike and wave discharges synchronous with bilateral arm myoclonias.
S. Mangano et al. / Brain & Development 27 (2005) 218–223220in all but one showing EEG abnormalities until 3 years of
age. All patients withdrew AED after a seizure-free period
of 3 years. During the follow-up, relapses were not
observed. At the end of follow-up (Table 2), two children
had mild and moderate mental retardation, respectively, and
showed other neuropsychological disorders: fine motor skill
deficits, attention deficits and language impairment. In these
patients the onset of MS was below 1 year of age and they
were the youngest (age: 7 months) of our cases. Three
children achieved a borderline IQ and one normal but low
IQ. They displayed neuropsychological disabilities includ-
ing learning disorders and attention deficits. Only one
patient showed normal IQ without neuropsychological and
behavioural problems.
The neuropsychological assessments during the follow-
up allow us to draw some developmental outline (Table 2).
At first assessment (T1) all but one child had a normal
developmental quotient (DQ). The evaluation of the child
with a low DQ was performed 21 months after onset of
MS. At second assessment (T2), after a mean period of 3
years from onset of seizures, two patients were mentally
retarded, one child showed a borderline IQ, and four
subjects had a normal mental development but two in the
lower normal range. The mean FSIQ of the group as a
whole was 78.6.All children revealed oppositional conduct, irritability,
aggressiveness and hyperkinesia.
At the end of follow-up (T3), there was no change among
FSIQ. The mean FSIQ of the group as a whole was 74. The
individual neuropsychological profiles were even in all but
one (case 2) with a significant higher verbal IQ score.
On TVLO two children failed in all subtests and met
criteria for language impairment (PZ0.01); four patients
showed deficits on two subtests (SR and TT) assessing
expressive and receptive syntax. The visual-motor inte-
gration abilities were at very low level in two patients.
Overall the patients have tended to progress at a low rate
but one has shown normal progress. In addition, five
children fulfilled DSM IV criteria for attention deficit
disorder. School achievement was poor in all but one and
four cases showed learning disorders. The patients attend
normal school but the two mentally retarded patients need a
support teacher.4. Discussion
The myoclonic epilepsies have been at the core of the
discussion on infantile epilepsies for many years. Since MS
characterize a broad spectrum of infantile epilepsies, seizure
Fig. 2. Patient 2: the interictal EEG shows no abnormalities during wakefulness.
S. Mangano et al. / Brain & Development 27 (2005) 218–223 221control and neuropsychological outcome may be different.
The Commission on Classification of Epilepsies and
Epileptic Syndromes has placed the BMEI, recognized by
Dravet and Bureau [1], among the IGE starting before 3
years [6]. The clinical feature is characterized by MS,
occurring in healthy infants between 4 and 36 months of
age, and sensitive to appropriate antiepileptic treatment. The
MS are associated with favourable prognosis and sometimes
with FC during the course of disease.
The early reports have emphasized normal developmen-
tal milestones and lack of seizures after AED withdrawal in
BMEI [7]. The few long-term follow-up studies have
pointed out mental retardation, hyperkinesias, learning
disabilities, attention deficit, or behavioural disorders
[2–5]. The incidence of these findings has been 58% in
Dravet’s series, 21% in Todt’s patients, 45% in Giovanardi
Rossi’s infants, and 10% in Lin’s cases.
The high rate of these disorders makes the prognosis,
previously defined, uncertain. Unfavourable cognitive and
behavioural outcome has been reported to be related to early
seizure onset, delayed start of treatment, personal history
with pathological events, and disturbed mother–infant
relationship [2].
Our results overlap with previous reports regarding
clinical and EEG features including family history of FC or
epilepsy, effective VPA treatment, interval between MS
onset and starting AED, and seizure outcome.At the end of follow-up, all but one of our children (86%)
showed less favourable neuropsychological and intellectual
outcome than those previously reported by Giovanardi
Rossi (45%) and by Lin (10%).
We believe that the reason for such a high rate of
unfavourable outcome among our patients may be mainly,
but not exclusively, related to the earlier onset of the
seizures. In this study we enrolled children whose onset of
MS was within 3 years of age while Giovanardi Rossi and
Lin in their investigations included patients over 3 years of
age, 3/11 cases and 4/10 cases, respectively.
In addition, MS onset within 14 months of age in 71%
(5/7) of our patients, in 55% (6/11) of Giovanardi Rossi’s
cases, and in no patient of Lin’s subjects; and finally
favourable outcome has been reported mainly in children
whose age of MS onset was later [4,5, the present study],
although this finding is not always significant in all
investigations [4].
Nevertheless, in our patients, other additional interact-
ing factors such as delayed start of treatment, efficacy of
AED, and other unknown factors may have played a role
in producing a less favourable outcome. In an another
explanation, a pre-existing mild static encephalopathy or a
minor brain dysfunction not detected by DQ test at this
early age period may have been associated with BMEI
predisposition, thus causing early onset MS, and later
neuropsychological problems. Although DQ test scores
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S. Mangano et al. / Brain & Development 27 (2005) 218–223222were within normal range in all but one patient who was
measured 21 months after the onset of MS, DQ test has a
limitation to reflect exact intelligence because it only
measures a global developmental function. However, we
believe that our patients did not reveal significant
problems nearly at onset of the disorder because we
carried out detailed neurological and developmental
examinations in addition to DQ test during the first
admission. We are conscious that our view may be not
conclusive considering also the limited number of case
studies up to now.
At the last examination, all children but two displayed a
low intellectual performance (Table 2). The group as a
whole showed a FSIQ below the population mean.
It is likely that BMEI does not exert, different from some
epileptic encephalopathies, a quick destroying effect but
interferes with the development of the growing functions,
and results in long-term neuropsychological disabilities.
Thus, the harmful effect of BMEI on basic cognitive
processes may induce very serious consequences on a wider
range of later abilities.
Whereas the immature brain does not show detectable
seizure-induced cell loss than the mature brain [8–10], there
is some evidence from animal studies that the neonatal
recurrent seizures may produce significant and often
irreversible alterations in the developing brain [11–13].
Following recurrent seizures during early development in
rats, mossy fiber sprouting and increased expression of
glutamate receptors in the hippocampus (CA3 and supra-
granular region of the dentate gyrus) are associated with
increase in seizure susceptibility and long-term impaired
visual-spatial learning and memory [11,14–16]. On the
other hand, since most mossy fibers are connected with
GABA inhibitory interneurons [17], it is unclear yet which
of the anatomical changes are responsible for the cognitive
impairment and the lower seizure threshold. In addition,
unlike adult rats, recurrent neonatal seizures are associated
with a remarkable decrease in neurogenesis of granule cells
of the dentate gyrus [18]. The mechanisms by which early
recurrent seizures result in cognitive impairment may be
more complex involving also the sequential expression of
receptors, and the formation and probably stabilization of
synapses [19].
Although the extrapolation of animal experiments to the
human condition is difficult, the seizure-induced brain
changes at different stages of development may lead to
different levels of neuropsychological dysfunction: the
earlier MS occur, the greater the range of impaired cognitive
abilities.
Our clinical data suggest that brain development may be
more vulnerable to BMEI within 2 years of age than later
age. After the seizure onset, our younger patients tend to
achieve a defective neuropsychological profile that shows
little changes over time. The seizure activity in the early
stage of brain development could induce an abnormal
arrangement of the underlying processes involved in
S. Mangano et al. / Brain & Development 27 (2005) 218–223 223the organization of the following complex cognitive
abilities. In summary, it is likely that the developmental
stage of the brain and the MS, interacting with other factors
mentioned above, could account for the different degrees
of neuropsychological dysfunctions found in patients
with BMEI.Acknowledgements
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